A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Cagrilintide
Related studies linked through entity extraction aliases.
Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
- Status
- RECRUITING
- Phase
- PHASE1
A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
- Status
- RECRUITING
- Phase
- PHASE1
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Status
- RECRUITING
- Phase
- PHASE3
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
- Status
- RECRUITING
- Phase
- PHASE1
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
- Status
- COMPLETED
- Phase
- PHASE2
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
- Status
- COMPLETED
- Phase
- PHASE3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- Status
- COMPLETED
- Phase
- PHASE3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
- Status
- COMPLETED
- Phase
- PHASE3
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
- Status
- COMPLETED
- Phase
- PHASE1
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
- Status
- COMPLETED
- Phase
- PHASE1
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
- Status
- COMPLETED
- Phase
- PHASE3
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
- Status
- COMPLETED
- Phase
- PHASE2
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3